MTD and DLT, measured by clinical and neurological examination, AEs, laboratory parameters. Throughout study [clinicaltrials_resource:f6b83de75eaf68d111772074399d2b8e]

MTD and DLT, measured by clinical and neurological examination, AEs, laboratory parameters. Throughout study [clinicaltrials_resource:f6b83de75eaf68d111772074399d2b8e]

500mg/m2 po bid (starting dose)
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:f6b83de75eaf68d111772074399d2b8e
A Study of Xeloda (Capecitabine) Plus Radiation Therapy in Children With Newly Diagnosed Gliomas [clinicaltrials:NCT00532948]
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

MTD and DLT, measured by clinical and neurological examination, AEs, laboratory parameters. Throughout study [clinicaltrials_resource:f6b83de75eaf68d111772074399d2b8e]

500mg/m2 po bid (starting dose)
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:f6b83de75eaf68d111772074399d2b8e
Bio2RDF identifier
f6b83de75eaf68d111772074399d2b8e
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:f6b83de75eaf68d111772074399d2b8e
measure [clinicaltrials_vocabulary:measure]
MTD and DLT, measured by clini ...... n, AEs, laboratory parameters.
time frame [clinicaltrials_vocabulary:time-frame]
description
500mg/m2 po bid (starting dose)
identifier
clinicaltrials_resource:f6b83de75eaf68d111772074399d2b8e
title
MTD and DLT, measured by clini ...... y parameters. Throughout study
@en
inDataset
type
label
MTD and DLT, measured by clini ...... 83de75eaf68d111772074399d2b8e]
@en